(Q38048852)

27 August 2017

Colistin: an update on the antibiotic of the 21st century (English)

1 reference

27 August 2017

0 references

Martine Reynaud-Gaubert

4

object named as

Martine Reynaud-Gaubert

0 references

Jean-Marc Rolain

5

object named as

Jean-Marc Rolain

1 reference

27 August 2017

Silpak Biswas

1

1 reference

27 August 2017

Jean-Michel Brunel

2

1 reference

27 August 2017

Jean-Christophe Dubus

3

1 reference

27 August 2017

Martine Reynaud-Gaubert

4

1 reference

27 August 2017

1 August 2012

1 reference

Expert Review of Anti-infective Therapy

27 August 2017

1 reference

27 August 2017

10

1 reference

27 August 2017

917-934

1 reference

27 August 2017

8

1 reference

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

27 August 2017

1 reference

Multidrug-resistant Gram-negative infections: what are the treatment options?

21 January 2018

1 reference

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

21 January 2018

1 reference

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

21 January 2018

1 reference

Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians

21 January 2018

1 reference

Colistin for Klebsiella pneumoniae-associated sepsis

21 January 2018

1 reference

Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options

21 January 2018

1 reference

Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin

21 January 2018

1 reference

21 January 2018

1 reference

A ten year review of colomycin

21 January 2018

1 reference

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

21 January 2018

1 reference

21 January 2018

1 reference

Colistin in the 21st century

21 January 2018

1 reference

Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

21 January 2018

1 reference

Dosing of colistin-back to basic PK/PD.

21 January 2018

1 reference

Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide.

21 January 2018

1 reference

Structure-Activity Relationship of Colistins

21 January 2018

1 reference

Semi-synthesis of polymyxin B (2-10) and colistin (2-10) analogs employing the Trichloroethoxycarbonyl (Troc) group for side chain protection of alpha,gamma-diaminobutyric acid residues

21 January 2018

1 reference

The chemistry of the polymyxin antibiotics

21 January 2018

1 reference

Solid-phase synthesis of polymyxin B1 and analogues via a safety-catch approach

21 January 2018

1 reference

The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature

21 January 2018

1 reference

Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis.

21 January 2018

1 reference

Colistin and polymyxin B in critical care.

21 January 2018

1 reference

Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients

21 January 2018

1 reference

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.

21 January 2018

1 reference

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

21 January 2018

1 reference

Renal and neurological side effects of colistin in critically ill patients

21 January 2018

1 reference

Colistin pharmacokinetics: the fog is lifting

21 January 2018

1 reference

Residue determination of two co-administered antibacterial agents--cephalexin and colistin--in calf tissues using high-performance liquid chromatography and microbiological methods

21 January 2018

1 reference

Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography

21 January 2018

1 reference

Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS.

21 January 2018

1 reference

Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration

21 January 2018

1 reference

Renal disposition of colistin in the isolated perfused rat kidney

21 January 2018

1 reference

Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses

21 January 2018

1 reference

Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration

21 January 2018

1 reference

Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis

21 January 2018

1 reference

Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.

21 January 2018

1 reference

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

21 January 2018

1 reference

High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.

21 January 2018

1 reference

Interaction of divalent cations and polymyxin B with lipopolysaccharide

21 January 2018

1 reference

Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance

21 January 2018

1 reference

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

21 January 2018

1 reference

Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics

21 January 2018

1 reference

BSAC standardized disc susceptibility testing method.

21 January 2018

1 reference

Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia

21 January 2018

1 reference

A reassessment of the in-vitro activity of colistin sulphomethate sodium.

21 January 2018

1 reference

In Vitro and In Vivo Activities of Minocycline and Other Antibiotics Against Acinetobacter ( Herellea-Mima )

21 January 2018

1 reference

In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany

21 January 2018

1 reference

In Vitro Activity of Antimicrobial Agents on Legionnaires Disease Bacterium

21 January 2018

1 reference

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

21 January 2018

1 reference

Susceptibility of clinical isolates of campylobacter pylori to 24 antimicrobial and anti-ulcer agents

21 January 2018

1 reference

Clonal analysis of Inquilinus limosus isolates from six cystic fibrosis patients and specific serum antibody response.

21 January 2018

1 reference

Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies

21 January 2018

1 reference

Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents

21 January 2018

1 reference

In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

21 January 2018

1 reference

Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.

21 January 2018

1 reference

Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A.

21 January 2018

1 reference

Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium

21 January 2018

1 reference

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

Colistin heteroresistance in acinetobacter and its association with previous colistin therapy

21 January 2018

1 reference

Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system

21 January 2018

1 reference

Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model

21 January 2018

1 reference

In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae

21 January 2018

1 reference

Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.

21 January 2018

1 reference

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

21 January 2018

1 reference

A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid A with 4-Amino-4-deoxy-L-arabinose. Identification and function oF UDP-4-deoxy-4-formamido-L-arabinose

21 January 2018

1 reference

Lipopolysaccharide endotoxins

21 January 2018

1 reference

Molecular basis of bacterial outer membrane permeability

21 January 2018

1 reference

PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A

21 January 2018

1 reference

Tyrosine phosphorylation of the UDP-glucose dehydrogenase of Escherichia coli is at the crossroads of colanic acid synthesis and polymyxin resistance

21 January 2018

1 reference

Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides

21 January 2018

1 reference

The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica

21 January 2018

1 reference

Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides

21 January 2018

1 reference

The Neisseria meningitidis capsule is important for intracellular survival in human cells

21 January 2018

1 reference

Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster

21 January 2018

1 reference

Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production

21 January 2018

1 reference

Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii.

21 January 2018

1 reference

Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

21 January 2018

1 reference

Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii.

21 January 2018

1 reference

Role of Pseudomonas aeruginosa outer membrane protein OprH in polymyxin and gentamicin resistance: isolation of an OprH-deficient mutant by gene replacement techniques

21 January 2018

1 reference

Low magnesium and phospholipid content of cell wals of Pseudomonas aeruginosa resistant to polymyxin.

21 January 2018

1 reference

Outer membrane proteins of polymyxin resistant Pseudomonas aeruginosa: effect of magnesium depletion.

21 January 2018

1 reference

PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance

21 January 2018

1 reference

Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.

21 January 2018

1 reference

Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS

21 January 2018

1 reference

Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant pmrA mutants of Salmonella typhimurium: a 31P-NMR study.

21 January 2018

1 reference

Salmonella typhimurium phoP virulence gene is a transcriptional regulator

21 January 2018

1 reference

Genetic analysis of colistin resistance in Salmonella enterica serovar Typhimurium

21 January 2018

1 reference

Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.

21 January 2018

1 reference

Acinetobacter baumannii Resistant to Colistin With Impaired Virulence: A Case Report From France

21 January 2018

1 reference

PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients

21 January 2018

1 reference

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

21 January 2018

1 reference

Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies

21 January 2018

1 reference

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.

21 January 2018

1 reference

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin.

21 January 2018

1 reference

Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea.

21 January 2018

1 reference

Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin

21 January 2018

1 reference

Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin

21 January 2018

1 reference

Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients

21 January 2018

1 reference

Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series

21 January 2018

1 reference

Colistimethate toxicity. Report of a fatal case in a previously healthy child

21 January 2018

1 reference

Neurotoxic and nephrotoxic effects of colistin in patients with renal disease

21 January 2018

1 reference

Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.

21 January 2018

1 reference

Isolation and air-liquid interface culture of human large airway and bronchiolar epithelial cells.

21 January 2018

1 reference

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

21 January 2018

1 reference

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

21 January 2018

1 reference

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

Predictors of acute kidney injury associated with intravenous colistin treatment

21 January 2018

1 reference

Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center

21 January 2018

1 reference

Colistin dosing and nephrotoxicity in a large community teaching hospital

21 January 2018

1 reference

Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii

21 January 2018

1 reference

Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

Polymyxins: Antimicrobial susceptibility concerns and therapeutic options

21 January 2018

1 reference

Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii

21 January 2018

1 reference

In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae

21 January 2018

1 reference

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa.

21 January 2018

1 reference

In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii.

21 January 2018

1 reference

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

21 January 2018

1 reference

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients.

21 January 2018

1 reference

Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.

21 January 2018

1 reference

Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options

21 January 2018

1 reference

Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii

21 January 2018

1 reference

Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii

21 January 2018

1 reference

Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates?

21 January 2018

1 reference

In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group

21 January 2018

1 reference

Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula

21 January 2018

1 reference

In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii.

21 January 2018

1 reference

Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia

21 January 2018

1 reference

Antibiotic resistance pattern among the Salmonella isolated from human, animal and meat in India.

21 January 2018

1 reference

Acinetobacter baumannii multidrug-resistant strain occurrence in liver recipients with reference to other high-risk groups.

21 January 2018

1 reference

Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals

21 January 2018

1 reference

Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae

21 January 2018

1 reference

Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin

21 January 2018

1 reference

Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin.

21 January 2018

1 reference

Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index

21 January 2018

1 reference

Prevalence of multidrug-resistant organisms recovered at a military burn center

21 January 2018

1 reference

Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.

21 January 2018

1 reference

Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan

21 January 2018

1 reference

Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study

21 January 2018

1 reference

In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy

21 January 2018

1 reference

In vitro antimicrobial synergy against imipenem-resistant Acinetobacter baumannii

21 January 2018

1 reference

Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel

21 January 2018

1 reference

Dissemination of IMP-1 metallo- beta -lactamase-producing Acinetobacter species in a Brazilian teaching hospital.

21 January 2018

1 reference

Genotypic diversity and antibiotic susceptibility of Acinetobacter baumannii isolates in a Bulgarian hospital

21 January 2018

1 reference

In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals

21 January 2018

1 reference

Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.

21 January 2018

1 reference

Antibiograms of resistant Gram-negative bacteria from Scottish CF patients

21 January 2018

1 reference

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

21 January 2018

1 reference

Characterization of the lipopolysaccharide from the polymyxin-resistantpmrAmutants ofSalmonella typhimurium

21 January 2018

1 reference

In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development

21 January 2018

1 reference

The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest and time-kill assay

21 January 2018

1 reference

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.

21 January 2018

1 reference

In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units

21 January 2018

1 reference

Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.

21 January 2018

1 reference

Characterization of Acinetobacter baumannii from intensive care units and home care patients in Palermo, Italy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.12.78

1 reference

27 August 2017

1 reference